2023 Together - IE217 - Should Rebate Value Alone Drive PBM Selection Decisions?
With the complexity of specialty medications becoming the focus of effective benefit design, how should health system decision-makers ask questions with greater impact that will lead to selecting the right pharmacy benefit management (PBM) partner? This session will address that question and more. Join us for this interprofessional discussion.
- Healthcare Quality Professionals
- Pharmacy Technicians
- Other Healthcare Professionals
Explain the impact of specialty medications on cost and quality.
Describe the experience of members utilizing the benefit plan.
Outline strategies to accelerate appropriate management of the pharmacy benefit plan.
Susan Wescott, RPh, MBA, Senior Director of Pharmacy, Managed Care, Mayo Clinic, Rochester, Minn., and Executive Lead, Clinical Services, Alluma
James Wilson, Chief Financial Officer, Mayo Clinic Health System, Rochester, Minn.
JoEllen Frain, Division Chair - Human Resources, Mayo Clinic, Rochester, Minn.
Priyesh Patel, PharmD, MBA, General Manager, Alluma, Irving, Texas (Moderator)
Disclosure of Financial Relationships:
Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
Susan Wescott, R.Ph., M.B.A., speaker for this educational activity, is an Executive Lead for Alluma.
All relevant financial relationships listed for these individual(s) have been mitigated.
All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Identification, Mitigation, and Disclosure of Relevant Financial Relationships
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Interprofessional Continuing Education (IPCE)
This activity was planned by, and for, the healthcare team, and learners will receive .75 Interprofessional Continuing Education (IPCE) credits for learning and change.
- 0.75 ACPE Pharmacist
- 0.75 ACPE Pharmacy Technician
- 0.75 AMA PRA Category 1 Credit™
- 0.75 ANCC
- 0.75 CPHQ – Certified Professional Healthcare Quality
- 0.75 General CE – Attendance
- 0.75 Interprofessional Continuing Education (IPCE)